openPR Logo
Press release

Only 4 weeks remain until SMi’s 3rd annual Lyophilization USA conference

10-18-2017 01:35 PM CET | Health & Medicine

Press release from: SMi Group

View Agenda

View Agenda

SMi’s Lyopihlization USA will gather leading experts to discuss the latest cutting-edge developments in freeze drying, as well as solutions to on-going industry challenges. A value-packed brochure with top pharma companies joining, including GSK, Tempris, Shire, Takeda Vaccines, Johnson & Johnson and more, who will be presenting a vast range of topics and issues within freeze-drying. http://www.lyophilization-usa.com/opr

Here is a summary of a few key sessions which cannot be missed:

[OPENING ADDRESS] Hydrogen Deuterium Exchange Mass Spectrometry for formulation/Process Optimization in Lyophilized Solids

- Basics of hydrogen deuterium exchange Mass Spectrometry (HDX-MS), for formulation and process optimization, will be briefly discussed.
- Impact of formulation parameters, i.e., protein: sucrose ratio, type of stabilizer etc. will be discussed.
- Impact of processing parameters, including controlled ice nucleation and annealing, on stress stability will be discussed.
- Correlation of HDX-MS data with stress stability would be performed to evaluate rank ordering of the impact of processing conditions.
Lokesh Kumar, Associate Scientist, Genentech

Stability of Sugar-Protein Lyophilized Formulations: Evaluation of Phase Separation and Mobility

- Basics of solid-state NMR spectroscopy as a technique for evaluating phase separation and mobility in sugar-protein formulations.
- Impact of sugar crystallization, relaxation times, and phase separation on protein stability will be discussed.
- Comparison of micro-environmental protonation states using solid-state NMR spectroscopy and visible probes will be shown.
Eric Munson, Professor, Pharmaceutical Sciences, University of Kentucky

Holistic Approach to Packaging and Innovative Design

- Case study on innovation in packaging of pharmaceuticals.
- Challenges designing packaging that ensures patient safety and meets regulatory requirements.
- Relating consumer- friendly packaging to lyophilized products.
Guido Schmitz, Head of Packaging & Technology Innovation, Bayer Consumer Care

[KEYNOTE ADDRESS] The development and scale up of a freeze drying cycle for biotherapeutics

- Freezing, primary drying and secondary drying design space.
- Scale up and effect of load configuration – secondary drying focus.
- Stability considerations and physical characterization on stability.
- Container closure selection and characterization.
Stuart Wang, Principal Scientist, Shire

Hear from Our Top Industry Experts:

- Andrea Weiland-Waibel, Managing Director, Explicat Pharma GmbH
- Charlie Tang, Associate Director, Formulation Development, Regeneron Pharmaceuticals
- Guido Schmitz, Global Head of Packaging & Technology Innovation, Bayer Consumer Care
- Jean- Francois Michiels, Senior Statistician, Arlenda
- Eric Munson, Professor, Pharmaceutical Sciences, University of Kentucky
- Kelly Forney Stevens, Drug Product Development, GSK Vaccines
- Melissa Lash, Scientist, Large Molecule Drug Development, Johnson & JohnsonWhy Not Attend The Pre-Conference Workshop?

[NOV 15th] Implementation of Quality by Design Principles into Lyophilization Processes

Why Attend?

- Learn about quality built into the process in the context of lyo
- Understand the interrelationship of formulation and process
- Learn how to determine the CFT
- What PAT techniques are available?
- Lyocycle robustness testings to evaluate the process boundaries, how to transfer this into commercial scale lyophilization
Workshop Leader: Andrea Weiland-Waibel, Managing Director, Explicat Pharma GmbH

These are just some of the unmissable program highlights for 2017. Visit the website to see a full speaker line-up and detailed conference agenda. www.lyophilization-usa.com/opr

For those looking to attend, check out the booking options online.

SMi Presents the 3rd Annual Conference on…
Lyophilization USA
Date: November 16th – 17th 2017
Location: Iselin, New Jersey
Website: www.lyophilization-usa.com/opr

Sponsored by: ELLAB | SCHOTT | TEMPRIS | W.L. GORE & ASSOCIATES, INC

---end---

Contact Information:

For all media inquiries contact Pav Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminster Bridge Rd, London SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Only 4 weeks remain until SMi’s 3rd annual Lyophilization USA conference here

News-ID: 778760 • Views:

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the